Dr. Narasimhan Mani

Dr. Narasimhan Mani is recorded as CFO at Scienture Holdings, Inc. (SCNX) since May 26, 2026 and Board Member and CEO at Scienture Holdings, Inc. (SCNX) since May 20, 2025. Scienture Holdings, Inc. reported in an 8-K filed May 29, 2026 that Dr. Narasimhan Mani was appointed Interim Chief Financial Officer ("Interim CFO"), effective May 26, 2026. The proxy statement of Scienture Holdings, Inc. reports total compensation of $1,265,169 for Dr. Narasimhan Mani in fiscal 2025, including a base salary of $333,167. Disclosed compensation is on record for 2 fiscal years. Scienture Holdings, Inc. is classified in the Pharmaceutical Retailers industry within the Healthcare sector. Other leadership on record at Scienture Holdings, Inc. includes Dr. Shankar Hariharan (CEO and Chairman), Narasimhan Mani (CEO, CFO and Board Member), Shankar Hariharan (CEO, Chairman and Board Member) and 7 others.